SCHEMBL18650266

SCHEMBL18650266

NC(=O)CNCCOC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.50
SLC6A1 P30531 1/20 0.39
SPHK2 Q9NRA0 1/20 0.38
SPHK1 Q9NYA1 1/20 0.38
CYP2C9 P11712 2/20 0.37
CYP3A4 P08684 1/20 0.37
KCNH2 Q12809 1/20 0.37
DUT P33316 1/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
KCNN4 O15554 1/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4391006 0.87 KIF11 (0.49) KIF11SLC6A1CYP2C9DUTKMT2A
SCHEMBL18650267 0.82 KIF11 (0.39) KIF11SLC6A1KDM4EALDH1A1HDAC6
SCHEMBL3931384 0.77 SLC6A11 (0.48) KIF11SLC6A1CYP3A4KMT2AKDM4E
SCHEMBL16220812 0.76 DRD4 (0.59) SPHK2SPHK1SMN1; SMN2
SCHEMBL28446874 0.74 KIF11 (0.52) KIF11SLC6A1CYP2C9CYP3A4KCNH2
SCHEMBL6239312 0.73 SMN1; SMN2 (0.52) SPHK2SPHK1CYP2C9KMT2AMEN1
SCHEMBL4390984 0.72 KIF11 (0.46) KIF11SLC6A1KMT2AALDH1A1MEN1
SCHEMBL11275984 0.71 KIF11 (0.74) KIF11SLC6A1CYP2C9DUTALDH1A1
SCHEMBL9039341 0.71 KIF11 (0.57) KIF11SLC6A1CYP2C9CYP3A4KCNH2
SCHEMBL5262054 0.70 KIF11 (0.51) KIF11SLC6A1CYP2C9CYP3A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170080391-A1 HIGHLY EFFICIENT REVERSE OSMOSIS FILTER E.W. - HYDROPHILIC PROCESSES LTD. (IL) 2017-03-23 US disclosed
US-20170080391-A1 HIGHLY EFFICIENT REVERSE OSMOSIS FILTER E.W. - HYDROPHILIC PROCESSES LTD. (IL) 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170080391-A1 HIGHLY EFFICIENT REVERSE OSMOSIS FILTER CUTA, AQP1, AQP3 KIF11 1986/4885SLC6A1 290/4885SPHK2 1573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.